Logos Global Management LP, 10% Owner at Verve Therapeutics, Inc. (VERV), bought 813,265 shares at $19.00 ($7.0M) on 2021-06-21, disclosed to the SEC on 2021-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 443,265 | $0 | 0.0% |
| 2 | $19.00 | 370,000 | $7.0M | 100.0% |
| Total | $8.64 avg | 813,265 | $7.0M | 100% |
| Filing → |
| DYN | BUY | 2020-09-23 | $13.3M | — | Filing → |